Cargando…

Developing Phytocompounds from Medicinal Plants as Immunomodulators

Imbalance or malfunction of the immune systems is associated with a range of chronic diseases including autoimmune diseases, allergies, cancers and others. Various innate and adaptive immune cells that are integrated in this complex networking system may represent promising targets for developing im...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Chih-Chun, Chen, Hui-Ming, Yang, Ning-Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150268/
https://www.ncbi.nlm.nih.gov/pubmed/32300254
http://dx.doi.org/10.1016/B978-0-12-394591-4.00004-0
_version_ 1783520991867043840
author Wen, Chih-Chun
Chen, Hui-Ming
Yang, Ning-Sun
author_facet Wen, Chih-Chun
Chen, Hui-Ming
Yang, Ning-Sun
author_sort Wen, Chih-Chun
collection PubMed
description Imbalance or malfunction of the immune systems is associated with a range of chronic diseases including autoimmune diseases, allergies, cancers and others. Various innate and adaptive immune cells that are integrated in this complex networking system may represent promising targets for developing immunotherapeutics for treating specific immune diseases. A spectrum of phytochemicals have been isolated, characterized and modified for development and use as prevention or treatment of human diseases. Many cytotoxic drugs and antibiotics have been developed from phytocompounds, but the application of traditional or new medicinal plants for use as immunomodulators in treating immune diseases is still relatively limited. In this review, a selected group of medicinal herbs, their derived crude or fractionated phytoextracts and the specific phytochemicals/phytocompounds isolated from them, as well as categorized phytocompound groups with specific chemical structures are discussed in terms of their immunomodulatory bioactivities. We also assess their potential for future development as immunomodulatory or inflammation-regulatory therapeutics or agents. New experimental approaches for evaluating the immunomodulatory activities of candidate phytomedicines are also discussed.
format Online
Article
Text
id pubmed-7150268
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71502682020-04-13 Developing Phytocompounds from Medicinal Plants as Immunomodulators Wen, Chih-Chun Chen, Hui-Ming Yang, Ning-Sun Adv Bot Res Article Imbalance or malfunction of the immune systems is associated with a range of chronic diseases including autoimmune diseases, allergies, cancers and others. Various innate and adaptive immune cells that are integrated in this complex networking system may represent promising targets for developing immunotherapeutics for treating specific immune diseases. A spectrum of phytochemicals have been isolated, characterized and modified for development and use as prevention or treatment of human diseases. Many cytotoxic drugs and antibiotics have been developed from phytocompounds, but the application of traditional or new medicinal plants for use as immunomodulators in treating immune diseases is still relatively limited. In this review, a selected group of medicinal herbs, their derived crude or fractionated phytoextracts and the specific phytochemicals/phytocompounds isolated from them, as well as categorized phytocompound groups with specific chemical structures are discussed in terms of their immunomodulatory bioactivities. We also assess their potential for future development as immunomodulatory or inflammation-regulatory therapeutics or agents. New experimental approaches for evaluating the immunomodulatory activities of candidate phytomedicines are also discussed. Elsevier Ltd. 2012 2012-06-19 /pmc/articles/PMC7150268/ /pubmed/32300254 http://dx.doi.org/10.1016/B978-0-12-394591-4.00004-0 Text en Copyright © 2012 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Wen, Chih-Chun
Chen, Hui-Ming
Yang, Ning-Sun
Developing Phytocompounds from Medicinal Plants as Immunomodulators
title Developing Phytocompounds from Medicinal Plants as Immunomodulators
title_full Developing Phytocompounds from Medicinal Plants as Immunomodulators
title_fullStr Developing Phytocompounds from Medicinal Plants as Immunomodulators
title_full_unstemmed Developing Phytocompounds from Medicinal Plants as Immunomodulators
title_short Developing Phytocompounds from Medicinal Plants as Immunomodulators
title_sort developing phytocompounds from medicinal plants as immunomodulators
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150268/
https://www.ncbi.nlm.nih.gov/pubmed/32300254
http://dx.doi.org/10.1016/B978-0-12-394591-4.00004-0
work_keys_str_mv AT wenchihchun developingphytocompoundsfrommedicinalplantsasimmunomodulators
AT chenhuiming developingphytocompoundsfrommedicinalplantsasimmunomodulators
AT yangningsun developingphytocompoundsfrommedicinalplantsasimmunomodulators